This is a multi-centre, single blind, randomized study. Patients admitted to hospital with acute decompensated heart failure will be randomized to biomarker guided discharge algorithm vs usual care in a 2:1 ratio. NTproBNP and other biomarkers will be measured within 24 hours of admission. The NTproBNP results will be used to further stratify participants randomized to the biomarker guided group into lower and medium to higher risk pathways. Biomarkers will be repeated after 2-3 days and again prior to discharge. Specific care pathways will be followed for each of the lower risk and medium-higher risk groups. Biomarkers will be repeated 30 days post discharge. Participants will be followed with a phone call at 3 months and return for a follow up visit at 6 months post discharge for outcome evaluation.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
the total number of days alive and out of hospital during the first 30 days of heart failure diagnosis
Timeframe: Randomization to 30 days post randomization
the total number of days alive and out of hospital during the first 30 days of heart failure diagnosis
Timeframe: Randomization to 30 days post randomization
the total number of days alive and out of hospital during the first 30 days of heart failure diagnosis
Timeframe: Randomization to 30 days post randomization